Patient Organizations

Many patient organizations around the country help support people with

chronic kidney disease

. Some offer kidney condition information and other resources, while others provide local community support to patients and their caregivers. A few of these groups include:

American Association of Kidney Patients (AAKP)

3505 E. Frontage Road,Suite 315
Tampa, FL 33607
(800) 749-2257
www.aakp.org

The American Kidney Fund

6110 Executive Blvd, Suite 1010
Rockville, MD 20852
(800) 638-8299
www.kidneyfund.org

National Kidney Foundation

30 East 33rd Street
New York, NY 10016
(800) 622-9010
www.kidney.org

National Kidney and Urologic Diseases Information

3 Information Way
Bethesda, MD 20892
(800) 891-5390
www.kidney.niddk.nih.gov or www.urologic.niddk.nih.gov

Renal Support Network (RSN)

1311 N. Maryland Avenue
Glendale, CA 91207
(818) 543-0896
Fax: (818) 244-9540
www.rsnhope.org

Important Safety Information
  • During clinical trials, the most common side effects of FOSRENOL were gastrointestinal, and included nausea, vomiting, and diarrhea. Nausea and vomiting generally lessened over time as patients continued with their treatment.
  • Patients who stopped treatment usually reported gastrointestinal side effects as the reason for stopping. Other side effects reported in trials included dialysis graft complications, headache, abdominal pain, and low blood pressure.
  • Although studies were not designed to detect differences in risk of bone fracture and mortality, there were no differences demonstrated in patients treated with FOSRENOL compared to alternative therapy for up to 3 years.
  • The duration of treatment exposure and time of observation in the clinical program were too short to conclude that FOSRENOL does not affect the risk of bone fracture or mortality beyond 3 years.
  • While lanthanum has been shown to accumulate in the GI tract, liver, and bone in animals, the clinical significance in humans is unknown.
  • If you suffer from acute stomach ulcer, colon inflammation and colon ulcers, Crohn's disease, or bowel obstruction, it is important to know that patients with these conditions were not included in FOSRENOL clinical studies — please discuss with your doctor.
  • Don't take FOSRENOL if you are nursing or pregnant, or if you are under 18 years of age.

Shire
©2008 Shire US Inc., Wayne, PA 19087-5367
(800) 828-2088. All rights reserved.

This site is strictly intended for US residents and is governed solely by US laws and governmental regulations. Please see our online privacy policy for more information.

While Shire US Inc. makes reasonable efforts to include accurate, up-to-date information on the site, Shire US Inc. makes no warranties or representations as to its accuracy. Shire US Inc. assumes no liability for any errors or omissions in the content of the site.

FOS-00086 08/08